- Home
- HAIN vs CYRX Comparison
HAIN vs CYRX Comparison
Compare HAIN & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAIN
- CYRX
- Stock Information
- Founded
- HAIN 1993
- CYRX 1999
- Country
- HAIN United States
- CYRX United States
- Employees
- HAIN N/A
- CYRX N/A
- Industry
- HAIN Packaged Foods
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- HAIN Consumer Staples
- CYRX Health Care
- Exchange
- HAIN Nasdaq
- CYRX Nasdaq
- Market Cap
- HAIN 445.6M
- CYRX 422.6M
- IPO Year
- HAIN 1993
- CYRX N/A
- Fundamental
- Price
- HAIN $4.86
- CYRX $8.16
- Analyst Decision
- HAIN Hold
- CYRX Buy
- Analyst Count
- HAIN 7
- CYRX 7
- Target Price
- HAIN $9.00
- CYRX $13.14
- AVG Volume (30 Days)
- HAIN 1.7M
- CYRX 261.6K
- Earning Date
- HAIN 02-05-2025
- CYRX 03-11-2025
- Dividend Yield
- HAIN N/A
- CYRX N/A
- EPS Growth
- HAIN N/A
- CYRX N/A
- EPS
- HAIN N/A
- CYRX N/A
- Revenue
- HAIN $1,705,853,000.00
- CYRX $226,113,000.00
- Revenue This Year
- HAIN N/A
- CYRX N/A
- Revenue Next Year
- HAIN $2.39
- CYRX $7.70
- P/E Ratio
- HAIN N/A
- CYRX N/A
- Revenue Growth
- HAIN N/A
- CYRX N/A
- 52 Week Low
- HAIN $4.47
- CYRX $5.32
- 52 Week High
- HAIN $11.68
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- HAIN 26.86
- CYRX 53.74
- Support Level
- HAIN $4.47
- CYRX $6.97
- Resistance Level
- HAIN $5.07
- CYRX $8.97
- Average True Range (ATR)
- HAIN 0.37
- CYRX 0.55
- MACD
- HAIN -0.05
- CYRX -0.08
- Stochastic Oscillator
- HAIN 20.42
- CYRX 59.50
About HAIN Hain Celestial Group Inc. (The)
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.